573 related articles for article (PubMed ID: 25611392)
1. MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET.
Li YQ; Ren XY; He QM; Xu YF; Tang XR; Sun Y; Zeng MS; Kang TB; Liu N; Ma J
Cell Death Dis; 2015 Jan; 6(1):e1618. PubMed ID: 25611392
[TBL] [Abstract][Full Text] [Related]
2. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X
J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387
[TBL] [Abstract][Full Text] [Related]
3. MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma.
Liu N; Tang LL; Sun Y; Cui RX; Wang HY; Huang BJ; He QM; Jiang W; Ma J
Cancer Lett; 2013 Feb; 329(2):181-8. PubMed ID: 23142282
[TBL] [Abstract][Full Text] [Related]
4. MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1.
Li YQ; Lu JH; Bao XM; Wang XF; Wu JH; Hong WQ
J Exp Clin Cancer Res; 2015 Oct; 34():130. PubMed ID: 26503504
[TBL] [Abstract][Full Text] [Related]
5. miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2.
Zhu HM; Jiang XS; Li HZ; Qian LX; Du MY; Lu ZW; Wu J; Tian XK; Fei Q; He X; Yin L
Cell Physiol Biochem; 2018; 49(4):1564-1576. PubMed ID: 30223264
[TBL] [Abstract][Full Text] [Related]
6. miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways.
He Q; Ren X; Chen J; Li Y; Tang X; Wen X; Yang X; Zhang J; Wang Y; Ma J; Liu N
Oncotarget; 2016 Jan; 7(3):3047-58. PubMed ID: 26655091
[TBL] [Abstract][Full Text] [Related]
7. MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma.
Liu N; Jiang N; Guo R; Jiang W; He QM; Xu YF; Li YQ; Tang LL; Mao YP; Sun Y; Ma J
Mol Cancer; 2013 Oct; 12(1):123. PubMed ID: 24138931
[TBL] [Abstract][Full Text] [Related]
8. MiR-124 suppresses tumor growth and metastasis by targeting Foxq1 in nasopharyngeal carcinoma.
Peng XH; Huang HR; Lu J; Liu X; Zhao FP; Zhang B; Lin SX; Wang L; Chen HH; Xu X; Wang F; Li XP
Mol Cancer; 2014 Aug; 13():186. PubMed ID: 25098939
[TBL] [Abstract][Full Text] [Related]
9. RBM24 suppresses cancer progression by upregulating miR-25 to target MALAT1 in nasopharyngeal carcinoma.
Hua WF; Zhong Q; Xia TL; Chen Q; Zhang MY; Zhou AJ; Tu ZW; Qu C; Li MZ; Xia YF; Wang HY; Xie D; Claret FX; Song EW; Zeng MS
Cell Death Dis; 2016 Sep; 7(9):e2352. PubMed ID: 27584791
[TBL] [Abstract][Full Text] [Related]
10. miR-539 induces cell cycle arrest in nasopharyngeal carcinoma by targeting cyclin-dependent kinase 4.
Lv LY; Wang YZ; Zhang Q; Zang HR; Wang XJ
Cell Biochem Funct; 2015 Dec; 33(8):534-40. PubMed ID: 26559153
[TBL] [Abstract][Full Text] [Related]
11. The effects of microRNA-98 inhibits cell proliferation and invasion by targeting STAT3 in nasopharyngeal carcinoma.
Liu J; Chen W; Chen Z; Wen J; Yu H; Wang F; Wu L; He X
Biomed Pharmacother; 2017 Sep; 93():869-878. PubMed ID: 28724212
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2.
Xu YF; Mao YP; Li YQ; Ren XY; He QM; Tang XR; Sun Y; Liu N; Ma J
Cancer Lett; 2015 Jul; 363(2):146-55. PubMed ID: 25892549
[TBL] [Abstract][Full Text] [Related]
13. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
[TBL] [Abstract][Full Text] [Related]
14. miR-491-5p suppresses cell growth and invasion by targeting Notch3 in nasopharyngeal carcinoma.
Zhang Q; Li Q; Xu T; Jiang H; Xu LG
Oncol Rep; 2016 Jun; 35(6):3541-7. PubMed ID: 27035429
[TBL] [Abstract][Full Text] [Related]
15. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
[TBL] [Abstract][Full Text] [Related]
16. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
Cui Z; Zhao Y
BMC Cancer; 2019 Jan; 19(1):104. PubMed ID: 30678643
[TBL] [Abstract][Full Text] [Related]
17. CircZNF609 promotes cell proliferation, migration, invasion, and glycolysis in nasopharyngeal carcinoma through regulating HRAS via miR-338-3p.
Liu Z; Liu F; Wang F; Yang X; Guo W
Mol Cell Biochem; 2021 Jan; 476(1):175-186. PubMed ID: 32970285
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-101 inhibits invasion and angiogenesis through targeting ITGA3 and its systemic delivery inhibits lung metastasis in nasopharyngeal carcinoma.
Tang XR; Wen X; He QM; Li YQ; Ren XY; Yang XJ; Zhang J; Wang YQ; Ma J; Liu N
Cell Death Dis; 2017 Jan; 8(1):e2566. PubMed ID: 28102841
[TBL] [Abstract][Full Text] [Related]
19. MiR-145, a microRNA targeting ADAM17, inhibits the invasion and migration of nasopharyngeal carcinoma cells.
Wu J; Yin L; Jiang N; Guo WJ; Gu JJ; Chen M; Xia YY; Wu JZ; Chen D; Wu JF; Wang DJ; Zong D; Zhang N; Ding K; Huang T; He X
Exp Cell Res; 2015 Nov; 338(2):232-8. PubMed ID: 26297956
[TBL] [Abstract][Full Text] [Related]
20. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
Wu A; Wu K; Li J; Mo Y; Lin Y; Wang Y; Shen X; Li S; Li L; Yang Z
J Transl Med; 2015 Mar; 13():105. PubMed ID: 25884389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
